Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
bioAffinity Technologies, Inc. ( (BIAF) ) has shared an announcement.
bioAffinity Technologies has appointed J. Michael Edwards as their new CFO, effective November 5, 2024. Edwards, with over 30 years of financial and strategic experience, including a previous tenure as bioAffinity’s CFO, will be steering the company’s financial direction amidst the commercialization of its novel noninvasive lung cancer detection test, CyPath® Lung. His solid background, including leading the company’s IPO and establishing financial infrastructure, positions him to drive growth and shareholder value as the company advances in its mission to improve cancer diagnostics and patient outcomes.
Find detailed analytics on BIAF stock on TipRanks’ Stock Analysis page.
